Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Gallbladder Neoplasms × Everolimus × Clear all

Phase

Phase 2/3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Tuberous Sclerosis 2 Autistic Disorder 2 Uterine Neoplasms 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Intellectual Disability 1 Hamartoma Syndrome, Multiple 1 Gastroenteropancreatic Neuroendocrine Tumors 1 Gallbladder Neoplasms 1 Adenoma, Islet Cell 1

Interventions

Gemcitabine 3 Cisplatin 3 Oxaliplatin 2 durvalumab 1 Standard of Care 1 Geriatric Assessment 1 Everolimus 1 Drug Therapy 1 Capecitabine 1 ARRY-334543 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05833815 2024-08-13

Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

Banaras Hindu University

Phase 2/3 Recruiting

Gastrointestinal

Gallbladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡